4.5 Article

Does reactivation of cytomegalovirus contribute to severe COVID-19 disease?

Journal

IMMUNITY & AGEING
Volume 18, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12979-021-00218-z

Keywords

-

Funding

  1. Swedish Medical Research Council [2019 - 01736]
  2. Formas [2019-01736] Funding Source: Formas
  3. Swedish Research Council [2019-01736] Funding Source: Swedish Research Council

Ask authors/readers for more resources

The majority of people infected with SARS-CoV-2 show no symptoms or have mild symptoms, but a small percentage may develop severe illness, especially among the elderly. It remains unclear why some individuals progress to severe COVID-19, and there may be a potential link to the reactivation of latent viruses.
The majority of people infected with SARS-CoV-2 are asymptomatic or have mild to moderate symptoms. However, for unknown reasons, about 15 % have severe pneumonia requiring hospital care and oxygen support, and about 5 % develop acute respiratory distress syndrome, septic shock, and multiorgan failure that result in a high mortality rate. The risk of severe COVID-19 is highest among those who are over 70 years of age. Why severe COVID-19 develops in some people but not others is not understood. Could some cases involve reactivation of latent cytomegalovirus (CMV)?

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available